An Introduction to Psychedelic Therapies: MDMA, ketamine and psilocybin
CPD
This session will explore the science and clinical applications of MDMA, ketamine and psilocybin, including their mechanisms of action, safety and emerging evidence base. Dr Sessa will also consider the role of psychedelics in supporting neuroplasticity and psychotherapy, alongside the latest developments and changing legal landscape within this field.
Dr Ben Sessa introduced the fascinating and rapidly emerging field of psychedelic-assisted therapy. He explored MDMA, ketamine and psilocybin-assisted therapies, including their pharmacology, mechanisms of action, clinical applications, safety and emerging evidence of efficacy.
Dr Sessa explored how trauma can contribute to psychological rigidity, and how psychedelics may increase neuronal flexibility and plasticity to support and enhance psychotherapy. The session considered the latest developments in psychedelic research and practice, as well as the current legal and regulatory landscape surrounding these therapies.
Recording: Watch Here